Summary. The effect of Bacteroides asaccharolyticus on the opsonisation and phagocytosis of gram-positive and gram-negative bacteria by human polymorphonuclear leukocytes (PMNL) was investigated. Uptake of most isolates of staphylococci, streptococci and clostridia by PMNL after opsonisation with serum treated with B. asaccharolyticus was largely unimpaired. The same treatment of serum before opsonisation of isolates of Pseudomonas, Enterobacter, Klebsiella and Gardnerella resulted in the uptake by PMNL varying with individual isolates; a large reduction occurred with some and none with others. Treatment of serum with B. fragilis lipopolysaccharide before opsonisation of Proteus mirabilis produced a marked reduction in uptake, whereas treatment with B. fragilis capsular polysaccharide had little effect.
Introduction
The ability of Bacteroides spp. to impair phagocytosis, not only of themselves but also of accompanying bacteria, has been suggested to be an important factor in the development of mixed infections with aerobic and anaerobic bacteria (Ingham et al., 1977) . Bacteroides can activate both the classical and alternative complement pathways (Bjornson, 1984) and depletion of serum complement by bacteroides, resulting in reduced opsonk activity, has been proposed as a possible mechanism for inhibition of phagocytosis (Tofte et al., 1980; Jones and Gemmell, 1982; Wade et a1.,1983; Vel et al., 1985) . The depletion by bacteroides of heat-labile serum factors necessary for intracellular killing of bacteria by polymorphonuclear leukocytes (PMNL) has also been reported (Ingham et a1., 198 1) .
There have been conflicting reports of the location of the components in the bacteroides cell that impair phagocytosis. The property has been said to be associated with: (a) the intact cell (Ingham et al., 1977, 198 1) ; (b) the extracellular products (Namavar et al., 1983) ; (c) the capsule (Connolly et al., 1984) ; (d) the whole cell but not the capsule (Wade et al., 1983) .
The ability of bacteroides to inhibit phagocytosis of other bacteria has been shown to be dependent on the particular isolate (Jones and Gemmell, 1982; Wade et al., 1983 , Vel et al., 1985 . These studies were restricted to experiments with Proteus spp. and Escherichia coli.
The aims of the present investigation were to determine the range of bacteria whose serum opsonisation and uptake by PMNL may be affected by bacteroides and to determine whether the capsular polysaccharide (CPS) and lipopolysaccharide (LPS) of B. fragilis inhibit phagocytosis.
Materials and methods

Bacteria
Fresh isolates from clinical material submitted to the Bacteriology Department, Royal Infirmary, Glasgow, were used except where stated otherwise. Pr. mirabilis strain NGHl and B. asaccharolyticus strain NGH4 were kindly provided by Dr H.R. Ingham, General Hospital, Newcastle upon Tyne.
Capsular polysaccharide (CPS) and lipopolysaccharide ( L P S )
Samples of CPS and LPS, extracted and purified by Sephacryl S-300 chromatography in a buffer with sodium deoxycholate 3%, from B. fragilis strain 23745, were kindly provided by Dr D. L. Kasper, Channing Laboratory, Harvard Medical School, Boston, MA, USA (Onderdonk ef al., 1977) . Both polysaccharides were dissolved in distilled water before use.
Cuitiuation of bacteroides.
B. asaccharolyticus strain NGH4 and B. fragilis strain 23745 were grown anaerobically for 48 h at 37°C on 506 horse-blood-agar plates (Columbia Agar; Oxoid). Growth was suspended in saline 0.850/, w/v to a concentration of 5 x lo8 bacteriajml, determined spectrophotometrically.
Prepurution of radioiabelled bacteria
Bacteria were radiolabelled by growth in MuellerHinton Broth (Oxoid) containing 3H-adenine (specific activity 25 Cijmmol; Radiochemical Centre Amersham) at a final concentration of 10 pCijml of broth. Clostridium spp. and Gardnerella caginalis were grown anaerobically in Brain Heart Infusion Broth (Oxoid). After incubation, the bacterial suspensions were centrifuged, washed three times with saline 0.85% and the final suspension adjusted to contain 5 x lo7 bacteriajml before opsonisation. Counts of radioactivity/O.l ml were in the range 10,000-20,000 cpm for the different target bacteria used in the study.
Treatment of serum with bacteroides cells, LPS and CPS
Equal volumes of normal human serum, diluted to 50% vdv with Hanks's Balanced Salts Solution containing gelatin 0.1 90 (gel-HBSS), and B. asaccharolyticus or B. Jragilis cell suspension were mixed and placed in an orbital incubator (Gallenkamp; shaking speed 150 rpm) for 15 min at 37'C. Bacteroides cells were removed by centrifugation (3000g for 15 min) and the serum used immediately for opsonisation. With LPS and CPS the procedure was the same except that the serum was not centrifuged.
Leukocyte preparation
Venous blood donated by human volunteers was heparinised and mixed with dextran (mol.wt 150,000; 6% w/v in saline 0.85%). After sedimentation of erythrocytes, the supernate was centrifuged and the pellet resuspended in ammonium chloride 0.87% to allow lysis of erythrocytes. The leukocytes were centrifuged and resuspended to contain 5 x lo6 PMNL/ml as determined with a haemacytometer.
Uptake of radiolabelled bacteria
The method of Verhoef et al. (1977) was followed. For each phagocytosis mixture, duplicate test vials containing 0.1 ml of radiolabelled, opsonised bacteria and 0.1 ml of the leukocyte suspension were incubated for 45 min at 37°C in an orbital incubator (shaking speed 150 rpm).
Duplicate controls containing gel-HBSS in place of the leukocyte suspension were included. After incubation, 3 ml of scintillation fluid (Aqualuma, Lumac Systems AG, Basle, Switzerland) were added to one of the tests and to one of the control vials. Measurement of radioactivity in these vials provided an estimate of the total number of bacteria present in each phagocytic mixture.
To the other test and control vials, 3 mi of ice-cold phosphate-buffered saline (PBS), pH 7.4, were added; the vials were centrifuged at lOOg for 5 min to sediment the PMNL and the supernatant fluid was discarded. These vials were washed twice more with PBS and 3 ml of scintillation fluid was then added to each vial. Measurement of radioactivity in these vials provided an estimate of the number of ingested bacteria present in each phagocytic mixture. The counts/ min of the contents of each vial were determined in a liquid scintillation counter (1210 Ultrobeta; LKB Instruments Ltd). The percentage uptake of labelled bacteria was calculated as follows: cpm (centrifuged mixture containing PMNL) cpm (uncentrifuged mixture containing PMNL) This value was corrected by subtracting the corresponding value obtained from the counts recorded for the vials that did not contain PMNL.
Opson isat ion Statistical analysis
Fresh human serum was obtained from the Haematology Department, Royal Infirmary, Glasgow, divided into 5-ml portions and stored at -7OC before use. For opsonisation, serum was diluted with an equal volume of gel-HBSS and this solution was mixed with an equal volume of radiolabelled bacterial suspension. The final concentration of serum in all opsonisation mixtures was 2.5"; viv irrespective of whether the serum had been previously treated with bacteroides cells, LPS or CPS or was untreated. Opsonisation was performed in an orbital incubator (shaking speed 150 rpm) at 37°C for 15 min, after which the suspension was centrifuged, the supernate discarded and the opsonised bacteria resuspended to the original concentration (i.e., 5 x 107fml) in fresh gel-HBSS.
Student's t test was used to assess significance; all experiments were performed at least twice.
Results
Efect of B. asaccharolyticus strain NGH4 on opsonisation and uptake of various isolates
Phagocytic uptake of Staphylococcus aureus isolates was mainly unaffected after opsonisation with serum treated with B. asaccharolyticus cells (Fig. 1) ; uptake of only one isolate was reduced to 70% of that of the untreated control and uptake of seven isolates was unaffected. Greater variation occurred with S. epidermidis isolates; uptake of one isolate was reduced to 55% and that of the other isolates by smaller amounts. With Streptococcus faecalis isolates there was little difference in uptake after opsonisation with bacteroides-treated serum, compared with that of the untreated control. The effect on Clostridium isolates was similar; uptake of only two of seven isolates was affected, being reduced to 60-70% of that of the untreated controls. With ON SERUM OPSONISATION 227 minor exceptions, it appeared that treatment of serum with bacteroides cells before opsonisation had little overall effect on uptake of the grampositive isolates tested. A much greater variation in the effect of bacteroides treatment of serum on opsonophagocytosis was seen with gram-negative bacteria (Fig 2) . Uptake of only four (of 14) Pseudomonas isolates was unaffected whereas uptake of the others was reduced by 8-65% compared with that of the untreated control. Enterobacter isolates could be divided into two distinct groups-those whose uptake was unaffected by bacteroides treatment of the serum and those whose uptake was reduced by 4040%. With all five G. vaginalis isolates, the uptake after bacteroides treatment of serum was markedly reduced by 50-85%. A wide variation was seen with Klebsiella isolates; the uptake of most was reduced by 50% or more after treatment of serum with bacteroides.
Efect of B. fragilis CPS and LPS on opsonisation and uptake of Pr. mirabilis
At a concentration of 20 ,ug/ml of serum, LPS treatment of serum before opsonisation of Pr. mirubifis reduced uptake to 42% of the untreated control; the reduction was to 20% when serum was treated with 5 x lo8 B. fragilis cells (Fig. 3) . At LPS concentration of 0.2 and 0.02 pg/ml of serum, uptake was reduced to 60% and 75% respectively. Although there was a slight reduction in uptake when serum was treated with CPS before opsonisation (Fig. 4) it was less throughout than when serum was treated with LPS, particularly when CPS was used at a concentration of 20 pg/ml, which resulted in an uptake 707; of the control value. The results with CPS concentrations of 0-2 and 0.02pg/ml(72% and 82") were not significantly different (p > 0.1) from those with 20 pg/ml.
Discussion
According to our results, the ability of bacteroides to inhibit the phagocytosis of other bacteria appears to vary for different target micro-organisms. With some species, such as S. aureus and Str. faecalis, in almost all cases phagocytosis was hardly affected by treatment of the opsonising serum with bacteroides cells. In contrast, the degree of inhibition by bacteroides varied greatly with individual isolates of Klebsiella. Similar variation has been found amongst isolates of E. coli (Jones and Gemmell, 1982; Wade et al., 1983; Vel et al., 1985) .
Surface structures are responsible for the activation and deposition of serum complement (Stendahl and Edebo, 1972; Wilkinson et al., 1979) . A possible explanation for the variation in impairment of phagocytosis by bacteroides may be differences in the surface structures amongst bacterial strains. Depletion of serum complement components by bacteroides has been proposed as a mechanism for impairment of phagocytosis (Tofte et al., 1980; Jones and Gemmell, 1982; Wade et al., 1983; Vel et al., 1985) . The amounts of serum required for opsonisation of bacteria vary; for example, S . aureus is efficiently phagocytosed after opsonisation with serum 5% v/v, whereas Pr. mirabilis requires 25% for equivalent phagocytosis (Jones and Gemmell, unpublished results) . Thus depletion of complement components by bacteroides may leave insufficient complement for opsonisation of isolates with a high serum requirement but sufficient for opsonisation and phagocytosis of those with a low requirement.
Both the classical and alternative complement pathways can be activated by bacteroides (Joiner et al., 1981; Bjornson et af., 1983) . It has been reported that certain Bacteroides spp. can enzymatically degrade C3 and C5 components of serum (Sundqvist et al., 1984 (Sundqvist et al., ,1985 , but this would appear not to be pertinent to the present investigation because heat-killed bacteroides organisms are as efficient in inhibiting phagocytosis as live cells (Ingham et af., 1977; Jones and Gemmell, 1982) . Although the CPS of B. fragilis is an important virulence factor (Onderdonk et al., 1977; Kasper et al., 1979) our results show that it has little activity in the inhibition of phagocytosis. This supports the findings of Wade et af. (1983), but not those of Connolly et aE. (1984) who reported that CPS inhibited phagocytosis. The LPS of B. fragilis, as purified by Sephacryl 300 chromatography , impaired phagocytosis in our experiments, an effect which may be associated with the known activation of the alternative complement pathway by LPS (Nygren et al., 1979) but not by CPS (Okuda et al., 1978) . It is of interest that the capsule of Str. pneumoniae is associated with resistance to phagocytosis (Wood, 1960) , but that the CPS of Str. pneumoniae does not inhibit phagocytosis in vitro, whereas mucopeptide does (Dhingra et al., 1977) .
In conclusion, our results indicate that the LPS but not the CPS of bacteroides cells is responsible for reducing the opsonic activity of serum complement. This reduction does not appear to be sufficient to affect the phagocytosis of most grampositive bacteria, but is sufficient to impair the phagocytosis of gram-negative bacteria to various degrees (depending upon individual isolates). It is possible that by this means bacteroides may increase the pathogenic potential of another bacterium by inhibiting its phagocytosis in vivo. Further investigation is necessary to establish the validity of this hypothesis.
